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ABSTRACT
Objective: We compared the distribution by wealth of
self-reported illness burden (estimated from validated
scales, biomarker and reported symptoms) for angina,
cataract, depression, diabetes and osteoarthritis,
with the distribution of self-reported medical diagnosis
and treatment. We aimed to determine if the greater
illness burden borne by poorer participants was
matched by appropriately higher levels of diagnosis
and treatment.
Design: The English Longitudinal Study of Ageing,
a panel study of 12 765 participants aged 50 years and
older in four waves from 2004 to 2011, selected
using a stratified random sample of households in
England. Distribution of illness burden, diagnosis and
treatment by wealth was estimated using regression
analysis.
Outcome measures: The main outcome measures
were ORs for the illness burden, diagnosis and
treatment, respectively, adjusted for age, sex and
wealth. We estimated the illness burden for angina with
the Rose Angina scale, diabetes with fasting
glycosylated haemoglobin, depression with the Centre
for Epidemiologic Studies Depression Scale,
osteoarthritis with self-reported pain and disability and
cataract with self-reported poor vision. Medical
diagnoses were self-reported for all conditions.
Treatment was defined as β-blocker prescription for
angina, surgery for osteoarthritis and cataract, and
receipt of predefined effective interventions for diabetes
and depression.
Results: Compared with the wealthiest, the least
wealthy participant had substantially higher odds for
illness burden from any of the five conditions at all
four time points, with ORs ranging from 4.2 (95% CI
2.6 to 6.8) for diabetes to 15.1 (11.4 to 20.0) for
osteoarthritis. The ORs for diagnosis and treatment
were smaller in all five conditions, and ranged from 0.9
(0.5 to 1.4) for diabetes treatment to 4.5 (3.3 to 6.0)
for angina diagnosis.
Conclusions: The substantially higher illness
burden in less wealthy participants was not matched
by appropriately higher levels of diagnosis and
treatment.
INTRODUCTION
Poverty is associated with poor health, poor
access to healthcare and poor health out-
comes in many countries and across different
healthcare systems.1–3 Much of this variation
is caused by recognised broad social determi-
nants of health.4 Considerable political effort
has been directed at attempts to narrow
health inequalities by reducing poverty and
social exclusion. However, as healthcare has
become more effective at improving health,
its potential contribution to ameliorating
health inequalities has increased. McKeown
demonstrated in the 1970s that health ser-
vices had contributed little to health
improvement,5 but the same claim could not
Strengths and limitations of this study
▪ The English Longitudinal Study of Ageing (ELSA)
is a unique single source of detailed data on socio-
economic status and health, and this is the first
study to compare inequalities in illness burden,
self-reported medical diagnosis and treatment of
long-term conditions in a panel study over time.
▪ Highly detailed measures of individual wealth
were used alongside standardised scales and
blood biomarker to assess the illness burden of
depression, angina and diabetes.
▪ Standardised scales were not included in ELSA
for osteoarthritis and cataract, so assessment of
illness burden for these two conditions was
based on attributed symptoms which were not
specific for osteoarthritis and cataract.
▪ The study used self-reported data collected using
an extensively tested structured questionnaire,
but no information from medical records was
collected.
▪ An analysis of pooled data from four waves of
ELSA was used to maximise the sample size,
and the main finding that less wealthy partici-
pants are relatively underdiagnosed requires val-
idation in a larger longitudinal study.
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be made today. The past 30 years have seen the intro-
duction of a wide range of effective interventions, par-
ticularly for the prevention and management of chronic
disease.6 Yet although these new interventions improve
health, they are not necessarily applied equally across
the population. Health inequalities will widen if effective
services are offered, or taken up, with greater frequency
by wealthier than less wealthy people. The reverse is also
true, however, and there is an opportunity for healthcare
to reduce social inequalities if it reaches those most in
need.7
Little is known about pathways into poor health. The
National Health Service provides medical care free at
point-of-need to all UK residents, but there is scope for
inequalities to occur in the pathway from identification
of early symptoms through diagnosis and on to effective
treatment. Individuals in more deprived social groups
may be more reluctant to present to doctors with their
symptoms and so may not receive a diagnosis.8 9
Diagnosis is a key step that has meaning for both patient
and physician in all health systems, and ‘diagnostic con-
fusion’ may act as a barrier to healthcare for vulnerable
populations.8 10 11 Previous studies have found socio-
economic variation in either diagnosis or treatment
rates, but have not been able to compare inequalities in
illness burden, rates of diagnosis and treatment modal-
ities in the same population.12–14
The English Longitudinal Study of Ageing (ELSA)
provides new data that can be used to identify barriers
to equitable receipt of healthcare, and constitutes a
unique source of information on illness burden, self-
reported medical diagnosis and treatment. Other data
sources cover symptoms or diagnosis or treatment, but
no other single source covers all three. ELSA collects
data on symptoms and validated markers of common
health conditions, as well as diagnosis and treatment. It
also contains detailed sociodemographic information,
including direct measures of personal wealth, on a
sample selected to be representative of the population
of England aged 50 years and older. These data can be
used to compare socioeconomic inequalities for several
conditions, providing insight into a healthcare system
with no direct financial barriers to treatment (the
National Health Service in England). We aimed to assess
socioeconomic inequalities in the burden of illness (esti-
mated by validated scales, biomarker and reported symp-
toms) of angina, cataract, depression, diabetes and
osteoarthritis, and compare them with inequalities in
self-reported medical diagnosis and treatment, in order
to determine whether key components of healthcare
were received equitably.
METHODS
We obtained data from the ELSA cohort, an interview
survey of a sample of the population aged 50 years or
older in England. The sample was selected from house-
holds that had previously responded to the Health
Survey for England, and drawn from selected postcode
sectors stratified by health authority and deprivation to
be representative of adults aged 50 or more living in
private households in England.15 Participants are inter-
viewed in their homes or care homes every 2 years about
a wide range of health, economic and social topics. We
used data collected from core participants who had
been interviewed in any of four waves of ELSA from
wave 2 in 2004–2005 until wave 5 in 2010–2011. Wave 2
was the first wave to include questions on receipt of
quality-indicated healthcare, and information was not
collected on every variable in every wave. We studied five
common and important long-term conditions: angina,
diabetes, depression, osteoarthritis and cataract.
Effective treatment is freely available for all five condi-
tions from the National Health Service.
Variables
We collected data on illness burden, self-reported
medical diagnosis and treatment of angina, cataract,
depression, diabetes and osteoarthritis. The illness
burden for angina was defined as grade 2 on the Rose
Angina scale (pain or discomfort in chest when walking
at an ordinary pace on the level on most occasions or
more often, which makes participant stop or slow down
if occurs while walking, and which then goes away within
10 min, and which includes either sternum (any level),
or left arm and left anterior chest). Illness burden for
diabetes was defined as a fasting glycosylated haemoglo-
bin level of >7.5%.16 Illness burden for depression was
defined as a score of 3 or more on the eight-item
Centre for Epidemiologic Studies Depression Scale
(CES-D). The application of these standardised scales in
ELSA has been described previously.1 Illness burden for
osteoarthritis was defined as self-reported pain in the
hip or knee of 5 or more on a scale of 0–10.17 Illness
burden for cataract was defined broadly as reporting
poor vision or blindness. Cataract is responsible for
about a quarter of poor vision in the UK, so this
measure is the least specific and includes those with
other causes of poor vision, such as age-related macular
degeneration, which is responsible for about a third of
poor vision.18 19
A medical diagnosis was considered to exist if a partici-
pant answered ‘yes’ when asked whether a doctor had
ever told them they had the condition of interest. For
arthritis, a follow-up question asked whether they had
been told they had osteoarthritis, rheumatoid or other
arthritis.
Treatment for depression and diabetes was defined by
reported achievement of quality of care indicators,
derived through a robust process of literature reviews,
expert panel assessment and piloting.20 21 For depres-
sion, the quality indicator was about receipt of treatment
since the previous wave: “if a person is diagnosed with
clinical depression, then antidepressive treatment,
talking treatment or electroconvulsive treatment should
be offered within 2 weeks after diagnosis unless within
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that period the patient has improved, or unless the
patient has substance abuse or dependence, in which
case treatment may wait until 8 weeks after the patient is
in a drug-or alcohol-free state.” For diabetes, treatment
was measurement of HbA1c or fructosamine levels in
the preceding 12 months. Treatment for angina was
defined as ever being offered or currently taking
β-blockers (ELSA variables hebeta or hebetb). Treatment
for osteoarthritis and cataract was defined as reporting
ever having had surgery for the condition. For osteoarth-
ritis, this excluded those with hips or knees replaced
due to fracture. Data on hip and knee replacements
were only available for respondents aged 60 and over,
and so respondents aged less than 60 years (n=3186)
were excluded from the analysis of osteoarthritis.
Wealth was defined as the sum of financial, physical
and housing wealth plus state and private pension
income. Age was categorised into three groups: 50–59,
60–74 and 75 years and older.
Analysis
We used two approaches to analysis, a main analysis
using serial cross-sectional data and then a subsidiary
analysis using longitudinal data. Multivariable logistic
regression analysis was used, with the outcome variables
defined as one of illness burden, self-reported medical
diagnosis or treatment for each of the five conditions in
each cross-sectional wave (STATA statistical software
V.12.1). This regression analysis was repeated for each of
the four waves of ELSA from 2004 to 2011 separately
and then ‘overall’ for all four waves combined. For the
‘overall’ analysis, the data were reshaped into ‘long’
format in Stata statistical software, with each participant
having a separate record for each wave. Intraperson cor-
relation of outcomes was accounted for using robust
adjustment with Stata, with each participant’s unique
identifier included in the regression equation as a
cluster variable. Missing data were excluded from the
analyses.
The independent variables were age group, sex and
slope order of inequality. We used the slope order of
inequality as an independent variable to estimate the
relationship between the outcome measures and the
categorised measure of wealth.22 23 The slope order of
inequality consisted of wealth quintiles with values of
0.1, 0.3, 0.5, 0.7 and 0.9, that is, the midpoints of each
quintile on a scale of zero (least wealthy) to one (most
wealthy). The slope order of inequality was modelled as
a continuous variable, so that the slope or coefficient of
a logit linear regression line across all five quintiles
represents the difference in outcome between the hypo-
thetically wealthiest and least wealthy participant.
Exponentiating this slope coefficient results in an OR,
which is the ratio of the odds of the outcome in the
wealthiest compared with the least wealthy participant.
This OR is also known as a relative index of inequality.22
Advantages of this method of quantifying inequality are
that it includes all participants, instead of just comparing
the highest and lowest quintiles, it accounts for the
number of participants in each category and it provides
a single overall measure of inequality.
We included all participants in the main cross-
sectional analysis in order to compare the distribution of
illness burden in the whole population with the distribu-
tions of diagnoses and treatments in the whole popula-
tion. This meant that diagnosis was assessed even in
those who did not meet the criteria for ‘illness burden’,
and treatment was assessed even in those with no diag-
nosis. For the subsidiary analysis using longitudinal data,
we estimated the OR of receiving a diagnosis by a subse-
quent wave only for those who had met the criteria for
‘illness burden’ in a previous wave, and then the likeli-
hood of receiving treatment only for those who had
received a diagnosis in a previous wave. This was a sub-
sidiary analysis as the number of participants that could
be followed over time in this manner was small, particu-
larly for treatment in angina and depression.
RESULTS
The whole sample (n=12 765) was composed of partici-
pants aged 50 years or more who had responded to at
least one wave of ELSA from 2004–2005 until
2010–2011. The response rate in 2004–2005 was
82%.24 25 In wave 5 (2010–2011), self-reported medical
diagnosis for all five conditions increased as wealth
decreased, for example, in depression from 4% in the
wealthiest quintile to 11% in the poorest (table 1).
There was little variation between the waves for each of
the five conditions (table 2).
The hypothetically least wealthy participant had sub-
stantially higher odds than the hypothetically most
wealthy of meeting the criteria for ‘illness burden’ from
any of the five conditions at all four time points (overall
OR ranged from 4.2 to 15.1; table 3). The least wealthy
participant also had higher odds of diagnosis (ORs
1.1–4.5) and either no different or relatively small odds
of treatment (ORs 0.9–2.6; table 3 and figure 1).
For angina, the overall OR for meeting the criteria for
‘illness burden’ was 7.6, indicating that the hypothetic-
ally least wealthy individual was seven times more likely
to have angina symptoms (defined by the Rose Angina
scale) than the wealthiest. The OR for self-reported
medical diagnosis was 4.5, suggesting that some less
wealthy people with angina symptoms had not received
a diagnosis of angina, as the expected OR for equitably
distributed diagnosis would have been 7.6. The OR for
treatment was 3.2, and again the expected ORs for equit-
ably distributed treatment would have been 7.6. For
depression, the overall OR for illness burden was 6.4, for
medical diagnosis was 3.3 and for treatment was 2.6,
again suggesting that some poorer people with symp-
toms of depression were less likely to have received a
diagnosis or indicated healthcare, as the expected ORs
for equitably distributed treatment would have been 6.4.
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For diabetes, the overall OR for illness burden was 4.2
and 4.0 for diagnosis, suggesting that for diabetes, diag-
nosis was distributed equitably. However, the OR for
treatment was 0.9 and not statistically significantly differ-
ent from 1, again suggesting that some less wealthy
people with medically diagnosed diabetes had not
received treatment, as the expected OR for equitably dis-
tributed treatment would have been 4.2.
The subsidiary analysis calculated the OR of receiving
a diagnosis by a subsequent wave only for those who had
met the criteria for ‘illness burden’ for the relevant
long-term condition in a previous wave, and then the
likelihood of receiving treatment only for those who had
received a medical diagnosis in a previous wave. The
substantial inequalities in the illness burden of
conditions by wealth are identical to table 3, as
expected, and subsequently the numbers of eligible par-
ticipants dwindle rapidly due to the nested nature of the
analysis, with some wide CI and 9 out of 10 results not
statistically significant (see online supplemental file 1).
DISCUSSION
We found that while there were strong inverse associa-
tions between wealth and the burden of illness (based
on validated scales, symptoms and biomarker) of a long-
term condition, there were smaller or absent inequalities
in receipt of self-reported medical diagnosis or treat-
ment for the conditions considered. This suggests that
the substantially higher illness burden in less wealthy
Table 1 Characteristics of the English Longitudinal Study of Ageing participants at wave 5 (2010–2011) and self-reported
medical diagnosis of angina, cataract, depression, diabetes and osteoarthritis
Whole sample, N Angina, % Cataract, % Depression, % Diabetes, % Osteoarthritis, %
Sex
Male 3886 8.2 13.4 5.4 13.3 19.8
Female 4843 6.3 20.4 7.8 9.4 32.9
Age (years)
50–59 1906 2.2 3.7 10.1 7.2 17.1
60–74 4766 5.8 14.5 7.0 11.0 28.1
75+ 2057 15.0 36.6 2.9 15.0 34.1
Wealth quintile*
1 1716 3.4 13.8 4.1 6.0 21.5
2 1714 4.9 15.5 5.9 8.0 24.2
3 1723 6.6 20.1 5.7 11.3 25.7
4 1716 8.2 18.6 6.7 13.6 31.6
5 1715 12.9 19.2 11.5 16.7 33.1
Missing 145 5.5 9.7 4.8 9.7 20.0
Total 8729 7.2 17.3 6.7 11.1 27.1
*1=Wealthiest quintile, 5=least wealthy quintile.
Table 2 Prevalence of illness burden, self-reported medical diagnosis and treatment for angina, cataract, depression,
diabetes and osteoarthritis in four waves of the English Longitudinal Study of Ageing
Angina
N (%)
Cataract
N (%)
Depression
N (%)
Diabetes
N (%)
Osteoarthritis
N (%)
Illness burden
Wave 2 (2004–2005) 397 (4.6) 308 (3.5) 2037 (23.4) 160 (1.8) 1106 (12.7)
Wave 3 (2006–2007) 300 (3.6) 317 (3.8) 1929 (23.3) NA 917 (11.1)
Wave 4 (2008–2009) 300 (3.1) 331 (3.5) 2049 (21.4) 220 (2.3) 1088 (11.4)
Wave 5 (2010–2011) 254 (2.9) 320 (3.7) 1956 (22.4) NA 1046 (12.0)
Medical diagnosis
Wave 2 (2004–2005) 668 (7.6) 1050 (12.1) 402 (4.6) 715 (8.2) 1861 (21.4)
Wave 3 (2006–2007) 591 (7.1) 1294 (15.7) 490 (5.9) 935 (11.3) 1952 (23.6)
Wave 4 (2008–2009) 645 (6.7) 1421 (14.8) 601 (6.3) 1215 (12.7) 2262 (23.6)
Wave 5 (2010–2011) 655 (7.5) 1566 (17.9) 602 (6.9) 1413 (16.2) 2416 (27.7)
Treatment
Wave 2 (2004–2005) 85 (1.0) 535 (6.2) 98 (1.1) 552 (6.4) 202 (2.3)
Wave 3 (2006–2007) NA 379 (4.9) NA 618 (7.5) 141 (1.7)
Wave 4 (2008–2009) NA 444 (4.6) 155 (1.6) 671 (7.0) 226 (2.4)
Wave 5 (2010–2011) 88 (1.0) 646 (7.4) NA 748 (8.6) 208 (2.4)
Total number of participants in each wave: wave 2: 8688; wave 3: 8268; wave 4: 9578; wave 5: 8729.
NA=data not available for that condition in that wave.
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participants was not matched by appropriately higher
levels of diagnosis and treatment, and that equitable
receipt of a medical diagnosis may have an important
role in reducing inequalities in health.
ELSA is a unique single source of detailed data on
socioeconomic status and health, and this is the first
study to compare inequalities in illness burden, self-
reported medical diagnosis and treatment of long-term
conditions in a panel study over time. ELSA used robust
measures of individual socioeconomic position, and
standardised scales and blood biomarker to assess health
status. This exploratory study has some limitations and
the results should be interpreted with caution and
tested in subsequent research. While standardised mea-
sures were used to estimate the illness burden of depres-
sion, angina and diabetes, symptoms alone were used
for osteoarthritis and cataract, and the attributed symp-
toms were not specific for osteoarthritis and cataract.
However, this lack of specificity is unlikely to vary with
wealth, and so is not likely to be an important source of
Table 3 Illness burden, self-reported medical diagnosis and treatment of angina, cataract, depression, diabetes and
osteoarthritis, comparing the least wealthy with the most wealthy: logistic regression
Angina Cataract Depression Diabetes Osteoarthritis
ORs (95% CI)
Wave 2* (2004–2005)
Illness burden 5.6 (3.8 to 8.3) 7.2 (4.5 to 11.5) 5.1 (4.3 to 6.2) 4.4 (2.5 to 8.0) 11.0 (8.1 to 14.9)
Medical diagnosis 2.9 (2.2 to 3.9) 1.3 (1.0 to 1.6) 4.8 (3.3 to 7.0) 3.1 (2.3 to 4.2) 1.6 (1.3 to 2.0)
Treatment 2.6 (1.2 to 5.7) 1.5 (1.0 to 2.2) 0.6 (0.1 to 2.9) 0.7 (0.3 to 1.5) 1.1 (0.7 to 1.9)
Wave 3* (2006–2007)
Illness burden 8.7 (5.5 to 13.8) 8.2 (5.1 to 13.1) 6.9 (5.7 to 8.5) 12.7 (9.1 to 17.8)
Medical diagnosis 4.9 (3.6 to 6.8) 1.2 (1.0 to 1.5) 0.7 (0.4 to 1.4) 3.4 (2.6 to 4.4) 0.6 (0.4 to 0.8)
Treatment 1.3 (0.8 to 1.9) 1.2 (0.6 to 2.4) 1.0 (0.6 to 1.9)
Wave 4* (2008–2009)
Illness burden 6.7 (4.2 to 10.5) 5.5 (3.6 to 8.6) 5.9 (4.9 to 7.1) 3.9 (2.4 to 6.4) 14.0 (10.3 to 19.1)
Medical diagnosis 4.3 (3.2 to 5.9) 1.1 (0.9 to 1.4) 0.7 (0.4 to 1.2) 3.9 (3.1 to 5.1) 0.6 (0.4 to 0.8)
Treatment 1.1 (0.7 to 1.6) 2.4 (1.0 to 5.9) 0.2 (0.1 to 0.6) 1.0 (0.6 to 1.6)
Wave 5* (2010–2011)
Illness burden 8.4 (5.1 to 13.7) 6.2 (3.9 to 9.9) 5.9 (4.8 to 7.1) 16.0 (11.7 to 21.8)
Medical diagnosis 5.3 (3.9 to 7.3) 1.3 (1.0 to 1.5) 1.7 (1.0 to 2.8) 4.3 (3.4 to 5.4) 0.6 (0.4 to 0.8)
Treatment 3.3 (1.5 to 7.3) 1.8 (1.2 to 2.6) 0.8 (0.4 to 1.6) 1.2 (0.7 to 2.0)
Overall†
Illness burden 7.6 (5.4 to 10.8) 8.0 (5.4 to 11.9) 6.4 (5.5 to 7.5) 4.2 (2.6 to 6.8) 15.1 (11.4 to 20.0)
Medical diagnosis 4.5 (3.3 to 6.0) 1.3 (1.1 to 1.5) 3.3 (2.4 to 4.5) 4.0 (3.1 to 5.2) 1.1 (0.9 to 1.3)
Treatment 3.2 (1.7 to 6.0) 1.3 (1.0 to 1.8) 2.6 (1.1 to 6.1) 0.9 (0.5 to 1.4) 1.2 (0.8 to 1.6)
Statistically significant ORs (where the 95% CIs do not include 1 before rounding to one decimal place) are shown in bold.
*ORs adjusted for age group and sex.
†ORs adjusted for age group, sex and unique participant identifier.
‡Analyses for osteoarthritis excluded those younger than 60 years, as data on osteoarthritis treatment were only collected in those aged 60 or
over.25a
Figure 1 Illness burden (in
blue), self-reported medical
diagnosis (in green) and
treatment (in red) of angina,
cataract, depression, diabetes
and osteoarthritis, comparing the
least wealthy with the most
wealthy: Overall ORs (adjusted
for age and sex) and 95%
confidence bars: logistic
regression.
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bias. Self-reported data may be a source of bias if self-
report varies by factors other than objective health
status, such as wealth or social experience. This is a
recognised problem with some self-reported morbidity
data, but is less of a problem with sensory assessment for
pain, which is essentially self-perceived, and where self-
report is the best means of assessment.26
We have not adjusted for health-related factors that are
also more prevalent in poorer populations, such as
smoking, obesity and comorbidity, because none of these
are a reason for not making a diagnosis. Comorbid condi-
tions are commoner in those with lower socioeconomic
status, but there is no evidence that comorbidities make a
new diagnosis less likely. On the contrary, a higher number
of comorbid conditions in older people may be associated
with higher quality of care.27 We found different patterns in
different conditions, which fits with other research showing
that wealth acts differently in different conditions, and for
example, has no association with referral for postmenopau-
sal bleeding.28 Major national policy interventions such as
the Quality and Outcomes Framework payment for per-
formance scheme in primary care29 have been associated
with improved healthcare for included conditions such as
angina and diabetes, more than for excluded conditions
such osteoarthritis and poor vision.30–32
The serial cross-sectional analysis of four waves of ELSA
included all eligible participants in each wave in order to
maximise the sample size. This approach meant that
some participants with a diagnosed condition would no
longer have had symptoms or raised biomarkers, if they
were being successfully treated. Examples would be dia-
betic participants whose blood sugar levels were being
successfully controlled by treatment, and participants
with successfully treated depression. We therefore
checked our main results with the secondary (longitu-
dinal) analysis, which assessed subsequent diagnosis in
those had met the criteria for ‘illness burden’, and subse-
quent treatment in those with a medical diagnosis, but
the number of participants who could be followed
through the waves in this way was too small to allow mean-
ingful conclusions to be drawn from the results.
Our results fit with previous findings that a greater
proportion of people in deprived groups had Rose
Angina, but there was no difference in the proportions
receiving a general practitioner diagnosis of coronary
heart disease.14 Care-seeking behaviour and patient pre-
ferences may differ with wealth. Given the same infor-
mation, patients may want fewer medical interventions
than their doctors recommend33 34 and pessimism
about availability of treatment may make older people
reluctant to seek help.35 Older people may view living
with symptoms (such as pain, or emotional problems) as
a normal part of ageing.36 The response of the primary
care physician may also vary with the wealth of the
patient. For example, the physician might be more likely
to consider symptoms of breathlessness as a medical
problem requiring a diagnosis, whereas aches and pains,
poor vision and low mood might be considered part of
the tapestry of life, or the natural ageing process.
Comorbidity is more common in deprived populations,
and may make diagnosis of all conditions harder for
doctors within the constraints of a short consultation.37
At a system level, the results may be partially explained
by wealthier people living in areas where there are more
healthcare resources. Wennberg introduced the concept
of ‘supply-sensitive care’ to describe how the quantity of
healthcare resources allocated to a particular population
was a major determinant of the frequency of use of
health services by that population, and gives an example
in which “a doubling of the supply of internists or cardi-
ologists results in roughly a halving of the interval
between repeat visits.”38 39 Where healthcare resources
are relatively plentiful, patients with chronic diseases will
consult more, use more diagnostic tests and be referred
to hospital more. Further research could helpfully inves-
tigate whether those missing out on diagnosis are not
accessing health services, or are seeing a doctor but not
being diagnosed. The participants were selected to be
nationally representative of the population of England,
and so the findings are likely to be generalisable to
England, but not to countries with different healthcare
systems. If validated, our findings that inequalities in
receipt of diagnoses are potential barriers to equitable
healthcare for five common long-term conditions
suggest that future policy interventions to reduce socio-
economic inequalities in healthcare should consider
improving access to diagnosis as well as treatment.
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